NuLYTELY Interactions
There are 396 drugs known to interact with NuLYTELY (polyethylene glycol 3350 with electrolytes), along with 7 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 35 are major, 360 are moderate, and 1 is minor.
- View all 396 medications that may interact with NuLYTELY
- View NuLYTELY alcohol/food interactions (1)
- View NuLYTELY disease interactions (7)
Most frequently checked interactions
View interaction reports for NuLYTELY (polyethylene glycol 3350 with electrolytes) and the medicines listed below.
- acetaminophen
- albuterol
- alpha-lipoic acid
- amitriptyline
- amlodipine
- amoxicillin
- aspirin
- atorvastatin
- baclofen
- Benadryl (diphenhydramine)
- ceftriaxone
- clonazepam
- docusate
- doxycycline
- ferrous sulfate
- Fish Oil (omega-3 polyunsaturated fatty acids)
- furosemide
- gabapentin
- ketoconazole topical
- lorazepam
- losartan
- magnesium citrate
- MiraLAX (polyethylene glycol 3350)
- Norco (acetaminophen / hydrocodone)
- omeprazole
- potassium chloride
- prednisone
- ProAir HFA (albuterol)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
NuLYTELY alcohol/food interactions
There is 1 alcohol/food interaction with NuLYTELY (polyethylene glycol 3350 with electrolytes).
NuLYTELY disease interactions
There are 7 disease interactions with NuLYTELY (polyethylene glycol 3350 with electrolytes) which include:
- inflammatory bowel disease
- intestinal obstruction disorders
- GI obstruction/perforation
- arrhythmias
- impaired gag reflex
- renal disease
- seizures
More about NuLYTELY (polyethylene glycol 3350 with electrolytes)
- NuLYTELY consumer information
- Compare alternatives
- Reviews (14)
- Side effects
- Dosage information
- During pregnancy
- Drug class: laxatives
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.